Cloud Concinnity ® Request a Demo
Blog

Trial Technology Doesn't Reduce Complexity, It Relocates It

Clinical trials run on more specialized technology than they used to. Electronic data capture systems, safety databases, imaging platforms, site and vendor management tools: each one exists to solve a specific problem well, and each one has generally made that specific piece of the work better. What gets less attention is what happens on top of all of them: coordinating the people, decisions, and documents that connect one system to the next. Adding technology does not make that coordination problem smaller. It usually makes it bigger, because there are now more systems, more owners, and more handoffs to keep aligned.

More Systems, More Seams

Every system a trial adopts has a boundary: the point where its data, its users, or its workflow ends and someone else’s begins. A protocol amendment approved in one place has to be reflected in training records somewhere else. A safety signal identified in one system may need a committee review that happens nowhere near it. A document version finalized in one tool has to be the same version everyone downstream is actually working from.

None of that coordination lives inside any single system, because no single system was built to own it. It falls, by default, to whoever notices the gap: a study coordinator tracking versions in a spreadsheet, a project manager chasing signatures over email, an administrator trying to reconstruct which decision happened first when two systems disagree. That work is invisible until it is missed, and it grows in direct proportion to how many specialized systems a trial is running.

The Point Solution Trap

It is tempting to treat this as a problem each new system will eventually solve on its own, once it adds one more integration or one more reporting feature. In practice, a system built to capture data well is rarely also the right place to govern a cross-functional approval, and a system built to manage safety signals is rarely the right place to run a steering committee vote. Asking a point solution to also be the coordination layer usually means it does neither job cleanly.

The more durable answer is to treat coordination as its own layer of work, distinct from any single system of record, with its own standard for how a decision gets made, documented, and closed out regardless of which system originated it or which one the outcome eventually lands in.

This is not an argument against adopting new systems when they genuinely improve a specific piece of trial execution. It is an argument against expecting each new system to also absorb the coordination overhead it creates. A team that keeps waiting for the next tool to finally close the gap between systems tends to find that the gap simply moves, rather than closes, with every new addition to the stack.

What Gets Missed When Coordination Has No Owner

The practical cost of an unowned coordination layer rarely shows up as a single dramatic failure. It shows up as small, recurring friction: a committee reviewing a document that turns out not to be the current version, a protocol change that reaches one site’s file before it reaches another’s, a status update that takes a status meeting to produce because no other view of it exists. Individually, each of these is a minor delay. Across a multi-year, multi-site trial, they accumulate into a meaningful share of the operational risk the team is carrying, distinct from anything happening inside any one system.

Coordination as Its Own Layer

This is the role an Enterprise Clinical Execution Platform is built to fill: not a replacement for the CTMS, the EDC, or the safety system, but the governed space alongside them where the meetings, votes, approvals, and protocol changes that connect them actually happen, with a documented audit trail as a byproduct of how the work was done rather than something assembled after the fact.

Four things stay constant regardless of which systems a given trial has adopted:

  • Control: the process for a decision is standardized once, rather than negotiated fresh every time two systems and their owners have to coordinate.
  • Oversight: the status of a cross-system decision is visible while it is still in progress, not just after someone compiles a status update.
  • Capacity: the manual reconciliation work of keeping systems aligned goes to the people managing the process, not the people who should be focused on the trial itself.
  • Inspection-Readiness: the record of what was decided, and how the decision reached every system it needed to reach, exists on demand rather than under deadline.

Coordination Overhead Does Not Announce Itself

Part of what makes this problem persistent is that coordination overhead rarely appears on a project plan. Nobody schedules time to reconcile which version everyone actually thinks is current, or to figure out which system’s record of a decision is the real one. It happens anyway, absorbed into whatever time is left after the work that was actually planned, which is exactly why it is easy to under-resource. A team that only measures the performance of its individual systems can look efficient on paper while still losing meaningful time to the coordination between them.

Technology Choices Change. The Need for This Doesn’t

The specific systems a sponsor or CRO adopts will keep changing as new tools solve new problems well. What does not change is the coordination work that sits between whatever systems are in place at a given time. A trial with more specialized technology is not automatically a better-coordinated trial; it is a trial with more seams that someone has to manage. Building a durable answer to that, rather than hoping the next new system will absorb the coordination work too, is what keeps growing technical sophistication from turning into growing operational risk.

See governed execution on your own trials.

Request a Demo